Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
75 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
Overview
This study is a comprehensive report on the Point of Care Diagnostics (POC) market, with particular focus on industry outlook, growth drivers, market segmentation, competitive scenario and critical success factors. This research report provides statistical data, including market size by product and application for historic years of 2012 and 2013, with forecast up to 2020.
The report firstly provides market segmentation, current market scenario, growth prospects and value chain analysis. Then the report analyzes the Asia Pacific Point of Care Diagnostics (POC) market dynamics in-depth which include growth feasibility analysis, market driver impact analysis, five force analysis, and PESTEL analysis. The growth feasibility analysis points out key areas in this industry that represent high growth opportunities for market players over the forecast period.
Additionally, this report includes comprehensive industry landscape, with market dynamics, drivers, restraints, and opportunities. This report will help you discover the latest market trends and reveal sources of future market growth for Asia Pacific Point of Care Diagnostics (POC) market. If you are looking for a detailed report on Point of Care Diagnostics (POC) market, our research will save you time and effort while empowering you to make informed decisions.
This research report on Point of Care Diagnostics (POC) market includes: Market estimate and forecast of Point of Care Diagnostics (POC) market Key factors driving the growth of Point of Care Diagnostics (POC) market Detailed profile of the key players operating in this market Five year forecasts of market trends and market growth Challenges and opportunities in Point of Care Diagnostics (POC) market Why buy this report? Point of Care Diagnostics (POC) market size, growth rate and forecast to 2020 Track key market trends, opportunities and threats Make informed decisions related to marketing, branding, strategy building, and market development Competitive landscape with company market share and detailed profiles of key market players
Table of Contents
Chapter 1. Executive Summary
1.1. Point of Care Diagnostics Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Point of Care Diagnostics Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Point of Care Diagnostics Market Dynamics
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Point of Care Diagnostics - Company Market Share Analysis
2.7. Point of Care Diagnostics Market PESTEL Analysis, 2012
Chapter 3. Point of Care Diagnostics Product Outlook
3.1. Blood Gas/Electrolytes (Centralized and Decentralized)
3.2. Infectious Diseases
3.3. Hospital Glucose Testing
3.4. Cardiac Markers
3.5. Hematology
3.6. Coagulation
3.7. Primary Care Systems (Lipid Profiling and HbA1c Tests)
3.8. Decentralized Clinical Chemistry
3.9. Urinalysis
3.10. Drug Abuse Testing
3.11. Fertility
3.12. OTC and Rapid Diagnostic Tests
Chapter 4. Point of Care Diagnostics End User Outlook
4.1. Hospitals
4.2. Assisted Living Healthcare Facilities
4.3. Laboratories
4.4. Home
4.5. Clinics
4.6. Others
Chapter 5. Point of Care Diagnostics Competitive landscape
5.1. Roche Diagnostics
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Abbott Laboratories
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Siemens Healthcare
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 Beckman Coulter Inc.
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 Becton Dickinson and Company
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 bioMérieux
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Johnson and Johnson
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 Abaxis Inc.
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 Alere Inc.
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
5.10 Danaher Corporation
5.10.1 Company Overview
5.10.2 Financial Performance
5.10.3 Product Benchmarking
5.10.4 Strategic Initiatives
5.11 Qiagen (AmniSure)
5.11.1 Company Overview
5.11.2 Financial Performance
5.11.3 Product Benchmarking
5.11.4 Strategic Initiatives
5.12 Spectral Diagnostics
5.12.1 Company Overview
5.12.2 Financial Performance
5.12.3 Product Benchmarking
5.12.4 Strategic Initiatives
5.13 Church & Dwight Co. Inc.
5.13.1 Company Overview
5.13.2 Financial Performance
5.13.3 Product Benchmarking
5.13.4 Strategic Initiatives
5.14 Trinity Biotech PLC
5.14.1 Company Overview
5.14.2 Financial Performance
5.14.3 Product Benchmarking
5.14.4 Strategic Initiatives
5.15 Nipro Diagnostics Inc.
5.15.1 Company Overview
5.15.2 Financial Performance
5.15.3 Product Benchmarking
5.15.4 Strategic Initiatives
5.16 Hemocue AB
5.16.1 Company Overview
5.16.2 Financial Performance
5.16.3 Product Benchmarking
5.16.4 Strategic Initiatives
5.17 Nova Biomedical
5.17.1 Company Overview
5.17.2 Financial Performance
5.17.3 Product Benchmarking
5.17.4 Strategic Initiatives
5.18 Pharmatech Inc.
5.18.1 Company Overview
5.18.2 Financial Performance
5.18.3 Product Benchmarking
5.18.4 Strategic Initiatives
5.19 International Technidyne Corporation (ITC)
5.19.1 Company Overview
5.19.2 Financial Performance
5.19.3 Product Benchmarking
5.19.4 Strategic Initiatives
5.20 Quidel Corporation
5.20.1 Company Overview
5.20.2 Financial Performance
.20.3 Product Benchmarking
5.20.4 Strategic Initiatives
5.21 Sekisui Diagnostics
5.21.1 Company Overview
5.21.2 Financial Performance
5.21.3 Product Benchmarking
5.21.4 Strategic Initiatives
5.22 OraSure Technologies Inc.
5.22.1 Company Overview
5.22.2 Financial Performance
5.22.3 Product Benchmarking
5.22.4 Strategic Initiatives
Chapter 6. Methodology and Scope
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
